The AACR-Novocure Tumor Treating Fields Research Grants represent a joint effort to promote and support independent investigators who are conducting innovative research focused on Tumor Treating Fields (TTFields; intermediate frequency, low intensity, alternating electric fields that disrupt cell division in cancer cells). These grants are intended to provide a deeper understanding of the mechanisms of action of this novel anti-cancer treatment modality and to accelerate the development of new treatment strategies to advance therapeutic options for cancer. The research proposed for funding should be basic or translational in nature, promoting the transition of in vitro work into in vivo systems. Proposals focused on 1) translational approaches, promoting the transition of in vitro work into in vivo systems, 2) combination therapies involving TTFields, or 3) bringing treatments involving TTFields to the clinic, are strongly encouraged.
Applications are invited from researchers affiliated with institutions that currently hold a Materials Transfer Agreement (MTA) with Novocure for use of its devices.
In addition, applications are invited from researchers that have not yet entered into a Materials Transfer Agreement (MTA) with Novocure. If selected for funding, Novocure will work with the institution to execute a MTA to provide the necessary devices to complete the research. For additional details, please see the Materials Transfer Agreement and Terms and Conditions.
Each grant provides $250,000 over two years for expenses related to the research project, which may include salary and benefits of the grant recipient and any collaborators**, postdoctoral or clinical research fellows, graduate students and/or research assistants; research/laboratory supplies; equipment; travel; publication charges for manuscripts that pertain directly to the funded project; other research expenses; and indirect costs. (**Note that inter-laboratory collaboration is encouraged.)